Editas Medicine Inc
EDIT
Get informed when a big investor buys or sells
+ FollowMarket Cap$441.97M
Close$
$-1.25
144.4% downside
Current Fair Value
144.4% downsideOvervalued by 144.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $441.97 Million |
|---|---|
| Enterprise Value | $307.98 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.8 |
| Beta | 2.1 |
| Outstanding Shares | 119,294,615 |
Return
| Return on Equity | -70.24% |
|---|---|
| Return on Assets | -31.15% |
| Return on Invested Capital | 62.24% |
Valuation & Multiples
| P/E Ratio | -3.85 |
|---|---|
| PEG | 5.86 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.97 |
| Enterprise Value to EBIT | 2.93 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
$2.85 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$3.74 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 68.82% |
|---|---|
| Total Calls | 11,023▼ 97.06% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.63%▼ 42.82% |
|---|---|
| Total Invested | $49.57M▼ 61.64% |
| Investors Holding | 80▼ 134.00% |
ESG Score
No data
About Editas Medicine Inc
CEO: Cynthia Collins